Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells

(2015) Faizan H Khan et al.   BMC GENOMICS

Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling

(2015) Vijayabaskar Pandian et al.   Stem Cell Research & Therapy

Understanding and targeting cancer stem cells: therapeutic implications and challenges

(2013) Ke Chen et al.   ACTA PHARMACOLOGICA SINICA

Novel Synthetic Monoketone Transmute Radiation-Triggered NFκB-Dependent TNFα Cross-Signaling Feedback Maintained NFκB and Favors Neuroblastoma Regression

(2013) Sheeja Aravindan et al.   PLoS One

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

(2012) Li Ding et al.   NATURE

Cancer sequencing unravels clonal evolution

(2012) Carlos Caldas   NATURE BIOTECHNOLOGY

Comparison of Clinical Data, CT, and Bone Histopathology in Unilateral Chronic Maxillary Sinusitis

(2012) Ben-Zion Joshua et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors

(2011) Hanna Kryh et al.   BMC GENOMICS

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

(2011) G Schleiermacher et al.   BRITISH JOURNAL OF CANCER

Radiation-triggered Tumor Necrosis Factor (TNF) α-NFκB Cross-signaling Favors Survival Advantage in Human Neuroblastoma Cells

(2011) Jamunarani Veeraraghavan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

(2011) Wendy B. London et al.   JOURNAL OF CLINICAL ONCOLOGY

Curcumin inhibits NFκB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells.

(2010) N Aravindan et al.   CANCER BIOLOGY & THERAPY

Cytogenetics and genetics of human cancer: methods and accomplishments

(2010) Avery A. Sandberg et al.   CANCER GENETICS AND CYTOGENETICS

Y Chromosome microdeletion and altered sperm quality in human males with high concentration of seminal hexachlorocyclohexane (HCH)

(2010) Faizan Haider Khan et al.   CHEMOSPHERE

Accumulation of Segmental Alterations Determines Progression in Neuroblastoma

(2010) Gudrun Schleiermacher et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials

(2010) Thorsten Simon et al.   PEDIATRIC BLOOD & CANCER

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

(2009) P F Ambros et al.   BRITISH JOURNAL OF CANCER

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry

(2009) Alberto Garaventa et al.   EUROPEAN JOURNAL OF CANCER

Disease control intervals in high-risk neuroblastoma

(2008) Victor M. Santana et al.   CANCER

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

(2008) Susan L. Cohn et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Stem Cells in Breast: Current Opinion and Future Challenges

(2008) Emmanuelle Charafe-Jauffret et al.   PATHOBIOLOGY